Multi Drug Resistant Organisms: Clinical Trials

6 trials for Multi Drug Resistant Organisms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Multi Drug Resistant Organisms: new trials by email Literature Review of Multi Drug Resistant Organisms trials Research Report on Multi Drug Resistant Organisms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients
verapamil - Multi Drug Resistant Organisms, Antibiotic Resistance
Not yet recruitingAssiut University1002026-05-012026-04-08
Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients
MDRO Rectal Screening, 30-Day Telephone Follow-Up - Multi Drug Resistant Organisms
RecruitingValeriu Gheorghita4002026-01-012026-03-12
Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
RESPIRE score - Pneumonia, Pneumonia - Bacterial
CompletedAzienda Ospedaliero-Universitaria Careggi3002022-01-012026-02-23
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases
Biological sample collection, Questionnaire, Medical examination - Clostridium Difficile Infection, Multi Drug Resistant Organisms
CompletedAzienda Ospedaliero-Universitaria Consorziale Policlinico di Bari2252021-02-082022-08-04
Prevention of Nosocomial Infections (CleanKids)
Health-care associated infection (HCAI) - Severe Acute Malnutrition, Health Care Associated Infection
Not applicableCompletedEpicentre49442016-09-052019-08-14
Active Bathing to Eliminate Infection (ABATE Infection) Trial
Arm 2: Decolonization - Healthcare Associated Infections, Methicillin Resistant Staphylococcus Aureus
Not applicableCompletedUniversity of California, Irvine532014-04-012019-07-12

Narrower conditions

Cross Infection (2)  ·  Clostridium Infections (1)  ·  Community-Acquired Pneumonia (1)  ·  Emergencies (1)  ·  Gastrointestinal Diseases (1)  ·  Hepatic Encephalopathy (1)  ·  Irritable Bowel Syndrome (1)  ·  Pneumonia (1)  ·  Pneumonia, Bacterial (1)  ·  Severe Acute Malnutrition (1)

Broader conditions

Infections (4)  ·  Disease Attributes (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Iatrogenic Disease (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Central Nervous System Diseases (1)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Community-Acquired Infections (1)  ·  Digestive System Diseases (1)

Interventions

Independent Medical Evaluation (1)  ·  Surveys and Questionnaires (1)  ·  Verapamil (1)

Sponsors

Assiut University (1)  ·  Azienda Ospedaliero-Universitaria Careggi (1)  ·  Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari (1)  ·  Epicentre (1)  ·  University of California, Irvine (1)  ·  Valeriu Gheorghita (1)

Countries

Italy (2)  ·  Romania (1)  ·  United States (1)

Top investigators

Daniel Gillen, PhD (1)  ·  Edward Septimus, MD (1)  ·  Giuseppe Losurdo, MD (1)  ·  Grace Lee, MD MPH (1)  ·  Jason Hickok, MBA, RN (1)  ·  John Jernigan, MD MS (1)  ·  Jonathan Perlin, MD PhD (1)  ·  Julia Moody, MS (1)  ·  Ken Kleinman, ScD (1)  ·  Mary Hayden, MD (1)  ·  Robert Weinstein, MD (1)  ·  Susan Huang, MD MPH (1)

Results publications

PMID 26772801, PMID 30850112, PMID 42238377

NIH funding

UH2AT007769 (1), UH3AI113337 (1)